African Pharmaceutical Review
.
African Pharmaceutical Review
.
Trending
Lonza completes first GMP product batch at new mammalian manufacturing facility
How to boost pharmaceutical manufacturing in Africa
Selumetinib shows efficacy in adult patients with neurofibromatosis
Write For Us
|
Advertise with us
Sign In
Subscribe
Home
News
Articles
Interviews
Videos
Webinars
Publications
Whitepapers/Application Notes
Events
Podcasts
Featured Companies
QA/QC
R&D
Supply Chain
Digitalization
Analytical Techniques
Manufacturing
Regulatory affairs
Biopharma
Drug delivery
Formulation
Subscribe
Sign In
News
Articles
Interviews
Videos
Webinars
Publications
Whitepapers/Application Notes
Events
Podcasts
News
View All
FDA accepts for review GSK’s new fully liquid shingles vaccine
by
APR Team
13 Jan, 2025
1 Mins Read
WHO prequalifies diagnostic test to minimize hemolysis from antimalarial drugs
by
APR Team
09 Jan, 2025
1 Mins Read
GSK’s investigational antibody-drug conjugate achieves breakthrough therapy designation
by
APR Team
08 Jan, 2025
2 Mins Read
Key Alzheimer’s Disease Treatment Approved in China
by
APR Team
18 Dec, 2024
1 Mins Read
Roche launches new innovative mass spectrometry solution
by
APR Team
18 Dec, 2024
1 Mins Read
GSK’s fully liquid meningococcal vaccine approved in Europe
by
APR Team
30 Nov, 2024
1 Mins Read
Novartis’ innovative breast cancer medicine gets approval in Europe
by
APR Team
30 Nov, 2024
1 Mins Read
AstraZeneca’s first in class therapy shows efficacy in metastatic prostate cancer
by
APR Team
26 Nov, 2024
1 Mins Read
FDA accepts for review GSK’s new multiple myeloma therapy
by
APR Team
26 Nov, 2024
1 Mins Read
Japan approves first RSV vaccine for adults aged 50 -59
by
APR Team
23 Nov, 2024
1 Mins Read
Second mpox vaccine receives WHO emergency use approval
by
APR Team
21 Nov, 2024
2 Mins Read
Lonza completes first GMP product batch at new mammalian manufacturing facility
by
APR Team
20 Nov, 2024
1 Mins Read
Drug shows reduced risk of progression to type 2 diabetes in pre-diabetics
by
APR Team
15 Nov, 2024
1 Mins Read
Selumetinib shows efficacy in adult patients with neurofibromatosis
by
APR Team
13 Nov, 2024
1 Mins Read
AbbVie’s emraclidine fails to demonstrate efficacy in management of schizophrenia
by
APR Team
12 Nov, 2024
1 Mins Read
FDA to remove phenylephrine as an active ingredient for nasal congestion
by
APR Team
09 Nov, 2024
1 Mins Read
Anti-asthmatic therapy shows efficacy in treatment of chronic rhinosinusitis with nasal polyps
by
APR Team
09 Nov, 2024
1 Mins Read
9 African countries most affected by the mpox outbreak get vaccines allocation
by
APR Team
06 Nov, 2024
2 Mins Read
Regeneron’s dupilumab has achieved approval in Europe as the first treatment approved for children with eosinophilic esophagitis
by
APR Team
06 Nov, 2024
1 Mins Read
Two biotechnology firms partner to develop new AI-powered biopharmaceuticals
by
APR Team
05 Nov, 2024
1 Mins Read
AbbVie and EvolveImmune Therapeutics partner to innovate new cancer biotherapies
by
APR Team
31 Oct, 2024
1 Mins Read
Bayer and Liveo Research unveil innovative, eco-friendly blister packaging solution
by
APR Team
31 Oct, 2024
2 Mins Read
GSK acquires new investigational therapy targeted for lupus treatment
by
APR Team
30 Oct, 2024
1 Mins Read
AstraZeneca’s brand of benralizumab gains approval in Europe
by
APR Team
29 Oct, 2024
1 Mins Read
AbbVie set to enhance its CNS product line with acquisition of Aliada therapeutics
by
APR Team
29 Oct, 2024
1 Mins Read
Organon finalizes acquisition of Dermavant for up to $1.2 billion
by
APR Team
28 Oct, 2024
1 Mins Read
Regeneron’s targeted therapy shows promise in chronic spontaneous urticaria treatment
by
APR Team
24 Oct, 2024
1 Mins Read
Pfizer’s RSV vaccine gets FDA nod for adults with increased risk of disease
by
APR Team
23 Oct, 2024
1 Mins Read
Oral semaglutide shows reduction in risk of major adverse cardiovascular events in diabetic patients
by
APR Team
22 Oct, 2024
1 Mins Read
Lonza extends partnership with biopharmaceutical company for supply of antibody drug conjugates
by
APR Team
22 Oct, 2024
1 Mins Read
WHO declares Egypt malaria-free
by
APR Team
22 Oct, 2024
1 Mins Read
First once-daily subcutaneous prophylactic treatment for hemophilia recommended for European approval
by
APR Team
20 Oct, 2024
1 Mins Read
Innovative subcutaneous combination therapy receives approval for Parkinson's disease
by
APR Team
18 Oct, 2024
1 Mins Read
GSK’s first-in-class antibiotic with new mechanism of action approved for priority review
by
APR Team
16 Oct, 2024
1 Mins Read
Lonza Finalizes Expansion of Its New Drug Product Services Facility
by
APR Team
15 Oct, 2024
0 Mins Read
Big step in breast cancer treatment as Roche’s new therapy gains FDA approval
by
APR Team
11 Oct, 2024
1 Mins Read
AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule
by
APR Team
07 Oct, 2024
1 Mins Read
Win for Africa as Gilead grants generic licensing for innovative HIV medicine
by
APR Team
03 Oct, 2024
1 Mins Read
Lonza acquires Roche’s biologics site for $1.2 billion
by
APR Team
02 Oct, 2024
1 Mins Read
Africa to receive one million mpox vaccines through new UNICEF deal
by
APR Team
30 Sep, 2024
2 Mins Read
FDA approves drug with new pharmacological approach to schizophrenia treatment
by
APR Team
27 Sep, 2024
1 Mins Read
Lonza Secures Long-Term Agreement to Supply Critical Cell Therapy for Sickle Cell Treatment
by
APR Team
24 Sep, 2024
1 Mins Read
GSK receives Positive EU opinion for fully liquid meningococcal vaccine
by
APR Team
24 Sep, 2024
0 Mins Read
AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment
by
APR Team
23 Sep, 2024
1 Mins Read
Team Europe, Rwanda sign agreements worth €40m to strengthen Rwanda’s pharma sector
by
APR Team
20 Sep, 2024
2 Mins Read
Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.
by
APR Team
20 Sep, 2024
1 Mins Read
China taps into Africa through strategic deal with Nigerian firm to fight HIV
by
APR Team
19 Sep, 2024
1 Mins Read
Roche’s Xofluza reduces transmission of flu viruses, global trial shows
by
APR Team
19 Sep, 2024
1 Mins Read
Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis
by
APR Team
18 Sep, 2024
2 Mins Read
Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.
by
APR Team
17 Sep, 2024
2 Mins Read
Big step as WHO prequalifies the first vaccine against mpox
by
APR Team
13 Sep, 2024
2 Mins Read
Eli Lilly, Eva Pharma partner to enhance access to key immunomodulatory drug across Africa.
by
APR Team
05 Sep, 2024
1 Mins Read
Nigeria becomes first African country to receive mpox vaccines
by
Bevin Likuyani
28 Aug, 2024
1 Mins Read
Nigeria Issues Five Alerts on Confirmed Counterfeit Medicines in August
by
Bevin Likuyani
23 Aug, 2024
3 Mins Read
WHO invites Mpox vaccine manufacturers to apply for emergency use listing
by
Bevin Likuyani
12 Aug, 2024
2 Mins Read
J&J agrees to drop price of TB drug in South Africa after intense pressure
by
Bevin Likuyani
11 Jul, 2024
1 Mins Read
SAHPRA signs MoU with Rwanda Food and Drug Authority
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
Pfizer Expected To Offload £2 billion Worth Of Haleon Shares
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
The African Pharmaceutical Technology Foundation Receives $12million To Operationalize And Recruit Pharma Expertise
by
Bevin Likuyani
19 Jun, 2024
2 Mins Read
New Country Ratifies The African Medicines Agency Treaty
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
Uganda set to roll out new injectable HIV prevention drug
by
Bevin Likuyani
19 Jun, 2024
2 Mins Read
Johnson & Johnson Makes Major Rebrand To Signal New Era
by
Bevin Likuyani
19 Jun, 2024
3 Mins Read
Cipla expands in South Africa with acquisition of Actor Pharma for $49million
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
South Africa : Pharmacists Now Allowed To Prescribe HIV/TB Medicines
by
Bevin Likuyani
19 Jun, 2024
2 Mins Read
Nigeria: Pfizer seeks collaboration in the fight against counterfeit medicines
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
Gambia: 70 children lost lives due to substandard cough syrups
by
Bevin Likuyani
19 Jun, 2024
2 Mins Read
Daewoong Pharmaceutical’s Fexuprazan looks into Africa
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
Malaria : 12 African countries to benefit from life saving vaccine
by
Bevin Likuyani
19 Jun, 2024
2 Mins Read
Nigeria sets pace with rollout of new meningitis vaccine
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
New Nation Has Officially Ratified The African Medicines Agency Treaty
by
Bevin Likuyani
19 Jun, 2024
2 Mins Read
GSK raises £1.25 billion from discounted sale of Haleon shares
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
New African Nation Reaches WHO Maturity Level 3 In Medicines Regulation
by
Bevin Likuyani
19 Jun, 2024
1 Mins Read
Get Our Latest News & Update
Submit Now
Follow Us: